Please try another search
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company’s therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Name | Age | Since | Title |
---|---|---|---|
Daniel Abate-Daga | - | 2018 | Member of Scientific Advisory Board |
H. Michael Shepard | - | - | Member of Scientific Advisory Board |
Linda L. Kelley | 68 | 2018 | Member of Scientific Advisory Board |
Jose Conejo-Garcia | - | 2018 | Member of Scientific Advisory Board |
Marco L. Davila | - | 2018 | Member of Scientific Advisory Board |
Lewis H. Titterton | 79 | 2012 | Lead Independent Director |
Ian Hector Frazer | - | 2019 | Member of Scientific Advisory Board |
Emily Gottschalk | 62 | 2019 | Independent Director |
Hope S. Rugo | - | 2023 | Member of Breast Cancer Clinical Advisory Board |
Brian Czerniecki | - | 2023 | Member of Breast Cancer Clinical Advisory Board |
G. Thomas Budd | - | 2023 | Member of Breast Cancer Clinical Advisory Board |
Lisa H. Butterfield | - | 2023 | Member of Breast Cancer Clinical Advisory Board |
Brian Leyland-Jones | 73 | 2023 | Member of Breast Cancer Clinical Advisory Board |
Daniel P. Heist | - | 2023 | Member of Cancer Business Advisory Board |
Karen E. Knudsen | - | 2023 | Member of Cancer Business Advisory Board |
Robert E. Youle | - | 2023 | Member of Cancer Business Advisory Board |
Len Lichtenfeld | - | 2023 | Member of Cancer Business Advisory Board |
Scarlott K. Mueller | - | 2023 | Member of Cancer Business Advisory Board |
Michael T. Marquardt | - | 2023 | Member of Cancer Business Advisory Board |
Gary M. Reedy | - | 2023 | Member of Cancer Business Advisory Board |
Arnold M. Baskies | 74 | 2018 | Member of SAB & Breast Cancer Clinical Advisory Board, Co-Chair of CBAB and Independent Director |
Mark A. Goldberg | 69 | 2023 | Member of Cancer Business Advisory Board |
Pamela D. Garzone | 68 | 2021 | Chief Development Officer & Chair Breast Cancer Clinical Advisory Board |
Amit Kumar | 60 | 2012 | CEO, Chairman & Co-Chair of CBAB |
Sanjay Juneja | - | 2024 | Member of Cancer Business Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review